Presentation TCT 2023

TCT 423: Long-term Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition with Evolocumab and Aortic Stenosis Events – An Analysis from FOURIER and FOURIER-OLE

Presenter: Prakriti Gaba

October 26, 2023

REGISTER for free or LOG IN to view this content

TCT 423: Long-term Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition with Evolocumab and Aortic Stenosis Events – An Analysis from FOURIER and FOURIER-OLE

Structural Heart

TCT 2023

Aortic Valve

Up Next

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

More slides +

Presentation TCT 2023

TCT 750: Outcomes beyond 10 years of transcatheter aortic valve replacement in high-risk patients with severe aortic valve stenosis

Presenter: Ines Richter

October 26, 2023

Presentation TCT 2023

TCT 115: Safe large bore access via the third part of the Axillary artery for mechanical circulatory support implantation

Presenter: Swaiman Singh

October 26, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.